Literature DB >> 19005

[Aminoacid-p-nitroanilides splitting activities in the mature human placenta (author's transl)].

E Held.   

Abstract

A long experience in the treatment of endometrial cancer shows that the therapeutic measures vary considerably with regard to the extention of the tumor, the age of the patient and her general condition. This circumstances and particularly the critical study of the therapeutical results give the limits, within a certain kind of operation can reasonably be recommended. The intercurrent deaths are an important factor in the statistical evaluation of therapeutical success. As long as the tumor is limited to the body of the uterus, the corrected 5-year recoveries are about 90%. Considering all the circumstances, it becomes obvious, that in this stage, the simple abdominal hysterectomy with removal of the adnexa is still the operation of choice. Beside the histological degree of differentiation, the depth of the muscular invasion is the most important prognostic factor which might lead to additional measures. Postoperative radiation therapy of the vagina reduces considerably the incidence possibility of vaginal apex recurrence. In stage II radical hysterectomy must be considered, although we are aware of the fact, that a simple hysterectomy and bilateral salpingo-oophorectomy combined with radiation treatment may yield just as good results. In the clinical stage III laparotomy ought to be used more frequently. Also in case of operative intervention additional radiotherapy is mostly useful.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 19005     DOI: 10.1007/BF02570656

Source DB:  PubMed          Journal:  Arch Gynakol        ISSN: 0003-9128


  18 in total

Review 1.  Treatment of adenocarcinoma of the endometrium.

Authors:  H W Jones
Journal:  Obstet Gynecol Surv       Date:  1975-03       Impact factor: 2.347

2.  THE TREATMENT OF CARCINOMA OF THE BODY OF THE UTERUS.

Authors:  A T RODEN
Journal:  Proc R Soc Med       Date:  1964-06

3.  CARCINOMA OF THE CORPUS UTERI.

Authors:  E W DAVIS
Journal:  Am J Obstet Gynecol       Date:  1964-01-15       Impact factor: 8.661

4.  A clinicopathologic study of surgically treated carcinoma of the endometrium with nodal metastasis.

Authors:  K W BARBER; M B DOCKERTY; J H PRAT
Journal:  Surg Gynecol Obstet       Date:  1962-11

5.  The Treatment of Carcinoma of the Body of the Uterus.

Authors:  W R Winterton
Journal:  Proc R Soc Med       Date:  1964-06

6.  [Prognostic factors in early endometrial carcinoma (FIGO stage I)].

Authors:  V Engeler
Journal:  Geburtshilfe Frauenheilkd       Date:  1976-07       Impact factor: 2.915

7.  Treatment of adenocarcinoma of the endometrium.

Authors:  R C Park; W E Patow; W M Petty; E A Zimmermann
Journal:  Gynecol Oncol       Date:  1974-04       Impact factor: 5.482

8.  Adenocarcinoma of the body of the uterus.

Authors:  B V Lewis; J A Stallworthy; R Cowdell
Journal:  J Obstet Gynaecol Br Commonw       Date:  1970-04

9.  A study of carcinoma of the endometrium.

Authors:  B M Dobbie; C W Taylor; J A Waterhouse
Journal:  J Obstet Gynaecol Br Commonw       Date:  1965-10

Review 10.  The role of radical hysterectomy in adenocarcinoma of the endometrium.

Authors:  F Rutledge
Journal:  Gynecol Oncol       Date:  1974-08       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.